Article info
Oral Sessions
Social and behavioural aspects of prevention oral session 4 - STI and HIV Risk Reduction Strategies: Considerations of cost, cost-effectiveness and potential impact
O2-S4.03 The cost-effectiveness of human papillomavirus vaccination of females over age 12 years in the USA
Citation
O2-S4.03 The cost-effectiveness of human papillomavirus vaccination of females over age 12 years in the USA
Publication history
- First published July 10, 2011.
Online issue publication
July 10, 2011
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.